Optimal Patient Selection for Stereotactic Body Radiotherapy

The Lancet Oncology - United Kingdom
doi 10.1016/s1470-2045(19)30761-2
Full Text
Abstract

Available in full text

Categories
Oncology
Date
Authors
Publisher

Elsevier BV

Related search

Optimal Patient Selection for Stereotactic Body Radiotherapy – Authors' Reply

The Lancet Oncology
Oncology
2019English

Optimal Stereotactic Body Radiotherapy Dosage for Hepatocellular Carcinoma

2020English

Stereotactic Body Radiotherapy for Pancreatic Cancer

Hong Kong Journal of Radiology
Nuclear MedicineRadiologyImaging
2017English

Consensus Statement From the International Stereotactic Body Radiotherapy Consortium for Head and Neck Carcinoma—Patient Selection and Pre- And Post-Stereotactic Body Radiation Therapy Evaluation

International Journal of Radiation Oncology Biology Physics
OncologyRadiologyCancer ResearchRadiationNuclear MedicineImaging
2016English

Stereotactic Body Radiotherapy for Prostate Cancer: Ready for Prime Time?

Journal of Radiation Oncology
OncologyRadiologyNuclear MedicineImaging
2012English

Stereotactic Body Radiotherapy of Lymph Node Oligometastases

Klinicka Onkologie
Oncology
2020English

Stereotactic Body Radiotherapy for 186 Patients With Inoperable Lung Metastases

International Journal of Radiation Oncology Biology Physics
OncologyRadiologyCancer ResearchRadiationNuclear MedicineImaging
2019English

Spatially Fractionated Stereotactic Body Radiotherapy (Lattice SBRT) for Large Tumors

2020English

Stereotactic Body Radiotherapy for Unresected Pancreatic Cancer: A Nationwide Review

Cancer
Cancer ResearchOncology
2017English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy